$55.76
3.01% day before yesterday
NYSE, May 30, 10:12 pm CET
ISIN
US0126531013
Symbol
ALB

Albemarle Stock price

$55.76
-2.79 4.77% 1M
-55.54 49.90% 6M
-30.32 35.22% YTD
-68.02 54.95% 1Y
-215.16 79.42% 3Y
-21.66 27.98% 5Y
-4.09 6.83% 10Y
NYSE, Closing price Fri, May 30 2025
-1.73 3.01%
ISIN
US0126531013
Symbol
ALB
Industry

Key metrics

Market capitalization $6.56b
Enterprise Value $8.58b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.68
P/S ratio (TTM) P/S ratio 1.29
P/B ratio (TTM) P/B ratio 0.65
Dividend yield 2.89%
Last dividend (FY24) $1.61
Revenue growth (TTM) Revenue growth -39.34%
Revenue (TTM) Revenue $5.09b
EBIT (operating result TTM) EBIT $-471.73m
Free Cash Flow (TTM) Free Cash Flow $-139.60m
Cash position $1.52b
EPS (TTM) EPS $-11.12
P/E forward negative
P/S forward 1.34
EV/Sales forward 1.75
Short interest 24.14%
Show more

Is Albemarle a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

Albemarle Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a Albemarle forecast:

9x Buy
32%
17x Hold
61%
2x Sell
7%

Analyst Opinions

28 Analysts have issued a Albemarle forecast:

Buy
32%
Hold
61%
Sell
7%

Financial data from Albemarle

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
5,094 5,094
39% 39%
100%
- Direct Costs 4,914 4,914
42% 42%
96%
180 180
558% 558%
4%
- Selling and Administrative Expenses 574 574
14% 14%
11%
- Research and Development Expense 77 77
13% 13%
2%
155 155
148% 148%
3%
- Depreciation and Amortization 627 627
34% 34%
12%
EBIT (Operating Income) EBIT -472 -472
40% 40%
-9%
Net Profit -1,307 -1,307
501% 501%
-26%

In millions USD.

Don't miss a Thing! We will send you all news about Albemarle directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Albemarle Stock News

Positive
24/7 Wall Street
2 days ago
Nucor (NUE), Albemarle (ALB), and West Pharmaceutical Services (WST) have provided reliable dividends and growth, and Wall Street sees them growing even more over the next year.
Positive
Seeking Alpha
5 days ago
Dividend Aristocrats have slightly outperformed the S&P 500 year-to-date, despite underperforming in April and May. Dividend growth remains robust, with 41 of 69 Aristocrats announcing increases in 2025 and the average growth rate at 4.75%. 22 Aristocrats appear both undervalued and offer a projected long-term annualized return of at least 10%, based on dividend yield theory and earnings growth.
Positive
Seeking Alpha
12 days ago
Many S&P 500 Dividend Aristocrats remain overvalued, but select high-yield 'Dogs' like Realty Income and Amcor offer attractive entry points for income investors. Analyst forecasts suggest the top ten Aristocrat Dogs could deliver 16% to 38% net gains by May 2026, with average risk below the market. Caution: Fourteen Aristocrats have negative free cash flow margins, making their dividends less ...
More Albemarle News

Company Profile

Albemarle Corp. is a specialty company, which engages in developing, manufacturing, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment engages in developing and manufacture of basic lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties and reagents. The Bromine Specialties segment consists of bromine and bromine-based business includes products used in fire safety solutions and other specialty chemicals applications. The Catalysts segment contain two product lines: clean fuels technologies, which is primarily composed of hydro processing catalysts, and heavy oil upgrading that comprises of fluidized catalytic cracking catalysts and additives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Head office United States
CEO Jerry Masters
Employees 8,300
Founded 1993
Website www.albemarle.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today